880 research outputs found
Co-estimation of state-of-charge and state-of-health for high-capacity lithium-ion batteries.
To address the challenges of efficient state monitoring of lithium-ion batteries in electric vehicles, a co-estimation algorithm of state-of-charge (SOC) and state-of-health (SOH) is developed. The algorithm integrates techniques of adaptive recursive least squares and dual adaptive extended Kalman filtering to enhance robustness, mitigate data saturation, and reduce the impact of colored noise. At 25C, the algorithm is tested and verified under dynamic stress test (DST) and Beijing bus DST conditions. Under the Beijing bus DST condition, the algorithm achieves a mean absolute error (MAE) of 0.17% and a root mean square error (RMSE) of 0.19% for SOC estimation, with a convergence time of 4 s. Under the DST condition, the corresponding values are 0.05% for MAE, 0.07% for RMSE, and 5 s for convergence time. Moreover, in this research, the SOH is described as having internal resistance. Under the Beijing bus DST condition, the MAE and the RMSE of the estimated internal resistance of the proposed approach are 0.018% and 0.075%, with the corresponding values of 0.014% and 0.043% under the DST condition. The results of the experiments provide empirical evidence for the challenges associated with the efficacious estimation of SOC and SOH
Cytoplasmic CUL9/PARC Ubiquitin Ligase Is a Tumor Suppressor and Promotes p53-Dependent Apoptosis
A wide range of cell stresses, including DNA damage, signal to p53 through post-translational modification of p53. The cytoplasmic functions of p53 are emerging as an important constituent of p53’s role in tumor suppression. Here we report that deletion of the Cul9 (formerly Parc) gene, which encodes an E3 ubiquitin ligase that binds to p53 and localizes in the cytoplasm, resulted in spontaneous tumor development, accelerated Eμ-Myc-induced lymphomagenesis and rendered mice susceptible to carcinogenesis. Cul9-p53 double mutant mice exhibited indistinguishable tumor phenotypes as p53 single mutant mice, indicating that the function of Cul9 in tumor suppression is largely mediated by p53. Deletion of Cul9 had no significant effect on cell cycle progression, but attenuated DNA damage-induced apoptosis. Ectopic expression of wild-type CUL9, but not a point mutant CUL9 deficient in p53 binding, promotes apoptosis. These results demonstrate CUL9 as a potential p53 activating E3 ligase in the cytoplasm
REX: Rapid Exploration and eXploitation for AI Agents
In this paper, we propose an enhanced approach for Rapid Exploration and
eXploitation for AI Agents called REX. Existing AutoGPT-style techniques have
inherent limitations, such as a heavy reliance on precise descriptions for
decision-making, and the lack of a systematic approach to leverage try-and-fail
procedures akin to traditional Reinforcement Learning (RL). REX introduces an
additional layer of rewards and integrates concepts similar to Upper Confidence
Bound (UCB) scores, leading to more robust and efficient AI agent performance.
This approach has the advantage of enabling the utilization of offline
behaviors from logs and allowing seamless integration with existing foundation
models while it does not require any model fine-tuning. Through comparative
analysis with existing methods such as Chain-of-Thoughts(CoT) and Reasoning viA
Planning(RAP), REX-based methods demonstrate comparable performance and, in
certain cases, even surpass the results achieved by these existing techniques.
Notably, REX-based methods exhibit remarkable reductions in execution time,
enhancing their practical applicability across a diverse set of scenarios
Loss of PDZK1 expression activates PI3K/AKT signaling via PTEN phosphorylation in gastric cancer
Phosphorylation of PTEN plays an important role in carcinogenesis and progression of gastric cancer. However, the underlying mechanism of PTEN phosphorylation regulation remains largely elusive. In the present study, PDZK1 was identified as a novel binding protein of PTEN by association of PTEN through its carboxyl terminus and PDZ domains of PDZK1. By direct interaction with PTEN, PDZK1 inhibited the phosphorylation of PTEN at S380/T382/T383 cluster and further enhanced the capacity of PTEN to suppress PI3K/AKT activation. PDZK1 suppressed gastric cancer cell proliferation by diminishing PI3K/AKT activation via inhibition of PTEN phosphorylation in vitro and in vivo. The expression of PDZK1 was frequently downregulated in gastric cancer specimens and correlated with progression and poor prognosis of gastric cancer patients. Downregulation of PDZK1 was associated with PTEN inactivation, AKT signaling and cell proliferation activation in clinical specimens. Thus, low levels of PDZK1 in gastric cancer specimens lead to increase proliferation of gastric cancer cells via phosphorylation of PTEN at the S380/T382/T383 cluster and constitutively activation of PI3K/AKT signaling, which results in poor prognosis of gastric cancer patients
Cutaneous immunoprofiles of three spotted fever group Rickettsia cases
Spotted fever group rickettsia (SFGR) can cause mild to fatal illness. The
early interaction between the host and rickettsia in skin is largely unknown, and the
pathogenesis of severe rickettsiosis remains an important topic. A surveillance of
SFGR infection by PCR of blood and skin biopsy specimens followed by sequencing
and immunohistochemical (IHC) detection was performed on patients with a recent
tick bite between 2013 and 2016. Humoral and cutaneous immunoprofiles were
evaluated in different SFGR cases by serum cytokine and chemokine detection, skin
IHC staining, and transcriptome sequencing (RNA-seq). A total of 111 SFGR cases
were identified, including 79 “Candidatus Rickettsia tarasevichiae,” 22 Rickettsia raoultii,
8 Rickettsia sibirica, and 2 Rickettsia heilongjiangensis cases. The sensitivity to detect
SFGR in skin biopsy specimens (9/24, 37.5%) was significantly higher than that
in blood samples (105/2,671, 3.9%) (P 0.05). As early as 1 day after the tick bite,
rickettsiae could be detected in the skin. R. sibirica infection was more severe than
“Ca. Rickettsia” and R. raoultii infections. Increased levels of serum interleukin-18 (IL-
18), IP10, and monokine induced by gamma interferon (MIG) and decreased levels of
IL-2 were observed in febrile patients infected with R. sibirica compared to those infected
with “Ca. Rickettsia.” RNA-seq and IHC staining could not discriminate between
SFGR-infected and uninfected tick bite skin lesions. However, the type I interferon
(IFN) response was differently expressed between R. sibirica and R. raoultii
infections at the cutaneous interface. It is concluded that skin biopsy specimens
were more reliable for the detection of SFGR infection in human patients although
the immunoprofile may be complicated by immunomodulators induced by the tick
bite.The Natural Science Foundation of China (81621005 and 81773492) and the State Key Research Development Program of China (2016YFC 1200301).https://iai.asm.orgam2020Veterinary Tropical Disease
Genetic Polymorphisms in CYP2E1: Association with Schizophrenia Susceptibility and Risperidone Response in the Chinese Han Population
CYP2E1 is a member of the cytochrome P450 superfamily, which is involved in the metabolism and activation of both endobiotics and xenobiotics. The genetic polymorphisms of CYP2E1 gene (Chromosome 10q26.3, Accession Number NC_000010.10) are reported to be related to the development of several mental diseases and to be involved in the clinical efficacy of some psychiatric medications. We investigated the possible association of CYP2E1 polymorphisms with susceptibility to schizophrenia in the Chinese Han Population as well as the relationship with response to risperidone in schizophrenia patients.In a case-control study, we identified 11 polymorphisms in the 5' flanking region of CYP2E1 in 228 schizophrenia patients and 384 healthy controls of Chinese Han origin. From among the cases, we chose 130 patients who had undergone 8 weeks of risperidone monotherapy to examine the relationship between their response to risperidone and CYP2E1 polymorphisms. Clinical efficacy was assessed using the Brief Psychiatric Rating Scale (BPRS).Statistically significant differences in allele or genotype frequencies were found between cases and controls at rs8192766 (genotype p = 0.0048, permutation p = 0.0483) and rs2070673 (allele: p = 0.0018, permutation p = 0.0199, OR = 1.4528 95%CI = 1.1487-1.8374; genotype: p = 0.0020, permutation p = 0.0225). In addition, a GTCAC haplotype containing 5 SNPs (rs3813867, rs2031920, rs2031921, rs3813870 and rs2031922) was observed to be significantly associated with schizophrenia (p = 7.47E-12, permutation p<0.0001). However, no association was found between CYP2E1 polymorphisms/haplotypes and risperidone response.Our results suggest that CYP2E1 may be a potential risk gene for schizophrenia in the Chinese Han population. However, polymorphisms of the CYP2E1 gene may not contribute significantly to individual differences in the therapeutic efficacy of risperidone. Further studies in larger groups are warranted to confirm our results
Corrigendum to: The TianQin project: current progress on science and technology
In the originally published version, this manuscript included an error related to indicating the corresponding author within the author list. This has now been corrected online to reflect the fact that author Jun Luo is the corresponding author of the article
The Role of SUMO-Conjugating Enzyme Ubc9 in the Neuroprotection of Isoflurane Preconditioning Against Ischemic Neuronal Injury
Finishing the euchromatic sequence of the human genome
The sequence of the human genome encodes the genetic instructions for human physiology, as well as rich information about human evolution. In 2001, the International Human Genome Sequencing Consortium reported a draft sequence of the euchromatic portion of the human genome. Since then, the international collaboration has worked to convert this draft into a genome sequence with high accuracy and nearly complete coverage. Here, we report the result of this finishing process. The current genome sequence (Build 35) contains 2.85 billion nucleotides interrupted by only 341 gaps. It covers ∼99% of the euchromatic genome and is accurate to an error rate of ∼1 event per 100,000 bases. Many of the remaining euchromatic gaps are associated with segmental duplications and will require focused work with new methods. The near-complete sequence, the first for a vertebrate, greatly improves the precision of biological analyses of the human genome including studies of gene number, birth and death. Notably, the human enome seems to encode only 20,000-25,000 protein-coding genes. The genome sequence reported here should serve as a firm foundation for biomedical research in the decades ahead
- …